COVID-19 Impact

You may see some delays in posting new content due to COVID-19. If you have any questions, please submit a message to PSNet Support.

PSNet: Patient Safety Network
Web Resource
Government Resource

Kaletra (lopinavir/ritonavir) oral solution.

Food and Drug Administration; FDA.

This announcement describes a fatal overdose of a protease inhibitor in an infant and discusses how to prevent such occurrences.